2016, Number 14
<< Back Next >>
waxapa 2016; 8 (14)
Síndrome de Aglutininas Frías como expresión paraneoplásica de un Linfoma de tiroides: Reporte de un caso
González MT, Cruz CY, Santos GH, Díaz SC, Selis PDL, Jiménez GJJ
Language: Spanish
References: 10
Page: 4-8
PDF size: 0. Kb.
ABSTRACT
The Cold agglutinin syndrome is a type of autoimmune hemolytic anemia of a low incidence, produced by antibodies which react at low temperatures with the own red blood cells of the patient, destroying them. But rare even is his appearing like paraneoplastic expression of a diffuse large B-cell lymphoma of thyroid.
The case is of a feminine patient of 65 years old with clynical, laboratory and histopatological findings of both illnesses.
The patient received quimiotherapy treatment for eight cycles, which produced a complete response of the malign illness and of the associated Hematologic Disorders. At present the patient is asynthomatic and controlled.
REFERENCES
Muñiz E, Canals C, Nogués N. Anemia hemolítica autoinmune y transfusión. En: Cortés A, León G, Muñoz M y Jaramillo S, Eds. Aplicaciones y práctica de la Medicina Transfusional. 1a ed. Santiago de Cali: GCIAMT;2012. p.135-752.
Murphy MF, Stanworth SJ. Haematological disease. En: Michael F. Murphy MF, Pamphilon DH, ed. Transfusion Medicine. 2nd ed. Oxford: Wiley-Blackwell; 2005. p.119-31.
Petz LD. Cold antibody autoimmune hemolytic anemias. Blood Rev. 2008;22:1–15.
Berentsen S, Tjønnfjord GE. Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood Rev.2012;26:107–15.
Berentsen S. How I manage cold agglutinin disease. Br J Haematol. 2011; 153(3):309–17.
Fatima S, Siddiqui WA, Alshehri A. Primary Thyroid Lymphoma: Case Series with Review of Literature. Indian J Hematol Blood Transfus (Sept 2014) 30(Suppl 1):S346–S348
Stein SA, Wartofsky L (2013) Primary thyroid lymphoma: a clinical review. J Clin Endocrinol Metab 98:3131–3138.
Yang L, Wang A, Zhang Y, Mu Y.12 cases of primary thyroid lymphoma in China. Journal of Endocrinological Investigation, July 2015, Volume 38, Issue 7, pp 739-744.
Lee E, Zamkoff KW, Gentile TC, Zimrin A. Rituxan in the treatment of auto-immune hemolytic anemia (AIHA). Blood. 2000;96:596a–7a.
Berentsen S, Tjonnfjord GE, Gjertsen BT, Hammerstron J, Langholm R, Sorbo JH. Rituxan (Rituximab) therapy for chronic cold agglutinin disease. Blood. 2000;96:524a.